Literature DB >> 7369975

Evaluation of an acute mountain sickness questionnaire: effects of intermediate-altitude staging upon subjective symptomatology.

D A Stamper, R T Sterner, S M Robinson.   

Abstract

Mesh:

Year:  1980        PMID: 7369975

Source DB:  PubMed          Journal:  Aviat Space Environ Med        ISSN: 0095-6562


× No keyword cloud information.
  7 in total

Review 1.  Acute mountain sickness. Effects and implications for exercise at intermediate altitudes.

Authors:  E C Pigman
Journal:  Sports Med       Date:  1991-08       Impact factor: 11.136

2.  Amelioration of acute mountain sickness: comparative study of acetazolamide and spironolactone.

Authors:  S C Jain; M V Singh; V M Sharma; S B Rawal; A K Tyagi
Journal:  Int J Biometeorol       Date:  1986-12       Impact factor: 3.787

3.  Simulated descent v dexamethasone in treatment of acute mountain sickness: a randomised trial.

Authors:  H R Keller; M Maggiorini; P Bärtsch; O Oelz
Journal:  BMJ       Date:  1995-05-13

4.  The effects of acetazolamide and spironolactone on the body water distribution of rabbits during acute exposure to simulated altitude.

Authors:  S C Jain; M V Singh; S B Rawal
Journal:  Int J Biometeorol       Date:  1984-05       Impact factor: 3.787

5.  Acetazolamide or dexamethasone use versus placebo to prevent acute mountain sickness on Mount Rainier.

Authors:  A J Ellsworth; E F Meyer; E B Larson
Journal:  West J Med       Date:  1991-03

6.  Impact of 2 days of staging at 2500-4300 m on sleep quality and quantity following subsequent exposure to 4300 m.

Authors:  Janet E Staab; Stephen R Muza; Charles S Fulco; Sean P Andrew; Beth A Beidleman
Journal:  Physiol Rep       Date:  2021-11

7.  New metric of hypoxic dose predicts altitude acclimatization status following various ascent profiles.

Authors:  Beth A Beidleman; Charles S Fulco; Allen Cymerman; Janet E Staab; Mark J Buller; Stephen R Muza
Journal:  Physiol Rep       Date:  2019-10
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.